Proteus mirabilis (MJA 2.6S) from saline-tolerant tilapia exhibits potent antagonistic activity against Vibrio spp., enhances immunity, controls \(\mathsf{NH_3}\) levels and improves growth and survival in juvenile giant tiger shrimp, Penaeus monodon
View/
Date
2022-08-10Page views
803ASFA keyword
AGROVOC keyword
Taxonomic term
Metadata
Show full item recordShare
Abstract
Of several isolates from saline-tolerant tilapia exhibiting anti-vibrio activity, an isolate that demonstrated inhibitory activity with the biggest zone of inhibition against the shrimp pathogens, Vibrio harveyi and V. parahaemolyticus were chosen and investigated in this study. The isolate showed significant inhibition against the shrimp pathogens, V. harveyi and V. parahaemolyticus in a competitive assay. Upon 16S rRNA sequencing, the isolate was identified as putative Proteus mirabilis (MJA 2.6S). P. mirabilis (MJA 2.6S) exhibited extracellular protease, cellulase and amylase activities. Pathogenicity tests showed that it was not pathogenic to the shrimp even at the highest concentration of 108 CFU ml−1. Further, P. mirabilis (MJA 2.6S) improved growth and survival, stimulated higher phenoloxidase and bactericidal activities in the shrimp host and protected it from V. harveyi experimental infection. In addition, the isolate P. mirabilis (MJA 2.6S) significantly reduced the ammonia level of the pond water samples in vitro. Taken together, the results clearly showed the strong probiotic potential of P. mirabilis (MJA 2.6S) in shrimp and hence further studies are needed to determine its wider application as a probiotic in P. monodon culture.
Keywords
aquaculture bioremediation probiotics Proteus mirabilis shrimp immunity Phenoloxidase proteaseSubjects
Proteolytic enzymes
Cellulase
Description
Online Version of Record before inclusion in an issue.
Suggested Citation
Apines-Amar, M. J., Caipang, C. M., Lopez, J. D. M., Murillo, M. N. A., Amar, E., Piñosa, L. A. G., & Pedroso, F. (2022). Proteus mirabilis (MJA 2.6S) from saline-tolerant tilapia exhibits potent antagonistic activity against Vibrio spp., enhances immunity, controls \(\mathsf{NH_3}\) levels and improves growth and survival in juvenile giant tiger shrimp, Penaeus monodon. Aquaculture Research , 53(16), 5510-5520. https://doi.org/10.1111/are.16033
Type
ArticleISSN
1355-557X; 1365-2109Collections
- Journal Articles [1266]
Related items
Showing items related by title, author, creator and subject.
-
Induction of immunity and resistance to white spot syndrome virus (WSSV) in shrimp Penaeus monodon (Fabricius) by synthetic oligodeoxynucleotide and bacterial DNA
Amar, Edgar C.
; Faisan, Joseph P., Jr. (University of the Philippines Los Baños, 2012)
Shrimps like all invertebrates are believed to lack true adaptive immunity but recent evidence indicate that they can be protected against pathogenic organisms by priming their immune system with immunostimulatory substances. Here, we describe results of investigation aimed to strengthen shrimp immunity as a preventive strategy against white spot syndrome virus (WSSV) infection. Oligodeoxynucleotides (ODNs) with and without Cytosine-Guanine (CpG) motifs, and Vibrio harveyi genomic DNA (VHD) were administered by intramuscular injection and shrimp responses were assessed by ex vivo assays and experimental infection trials. Results showed that CpG ODN significantly increased ex-vivo immunity indices such as total hemocyte count (THC), plasma agglutination titer (PAT) and hemocyte lysate agglutination titer (HLAT). VHD significantly increased immune indices such as THC, plasma total protein (PTP) and HLAT. Reverse (GpC) motifs increased THC only. At a lower viral challenge dose, both CpG and GpC motifs, and VHD, were able to reduce shrimp mortality significantly but only CpG and VHD did so at a higher challenge dose. Strengthening shrimp immunity by the use of immunostimulatory nucleotides and bacterial genomic DNA could be a feasible preventive approach in the management of WSSV infections in shrimp. -
Evaluation of dietary freeze-dried Chaetoceros calcitrans supplementation to control Vibrio harveyi infection on Penaeus monodon juvenile
; ; ; ; Amar, Edgar (Elsevier, 2014)
Effects of supplementation of diets with freeze-dried Chaetoceros calcitrans to control Vibrio harveyi infection are evaluated through immune responses, and disease resistance of juvenile Penaeus monodon. Total lipid and fatty acid profile of Chaetoceros calcitrans is also analyzed. A challenge infection with 107 cfu/mL concentration of Vibrio harveyi is intramuscularly injected to juvenile Penaeus monodon after 45 days of feeding of diets supplemented with 15 g/kg and 30 g/kg dried Chaetoceros calcitrans. The use of dried Chaetoceros calcitrans is compared with that of ß-1,3 glucan Curdlan, a commercial immune enhancer. Incorporation of 30 g/kg Chaetoceros calcitrans in the diet enhances the immune system of shrimp as effected by high prophenoloxidase activity and plasma protein concentration and is better compared to the commercially available Curdlan. Chaetoceros calcitrans also contains polyunsaturated fatty acids (PUFAs) such as linolenic acid and eicosapentanoic acid (EPA) which are responsible for its antibacterial action against Vibrio harveyi. All these biological activities of Chaetoceros calcitrans add up to increase resistance of the juvenile Penaeus monodon to vibriosis as shown by its high survival rate from the challenge infection with Vibrio harveyi. Therefore, it is worthwhile to use Chaetoceros calcitrans as supplementary feed. Its effect in increasing the immune competence coupled with its antibacterial action, make the shrimp resistant to luminous vibriosis that continues to affect the industry, thereby augmenting aquaculture production. -
Studies on the efficacy of Sarafin® (sarafloxacin hydrochloride) on vibrios associated with vibriosis in black tiger shrimp (Penaeus monodon)
Pakingking, Rolando V., Jr.; ; (Fish Health Section, Asian Fisheries Society, 2002)
In vitro activity of Sarafin® (sarafloxacin hydrochloride) was determined against 7 luminous Vibrio harveyi isolates and 3 non-luminous Vibrio species (V. parahaemolyticus, V. alginolyticus and Vibrio species) isolated from diseased shrimp (Penaeus monodon) and rearing water, a strain of V. anguillarum from diseased marine fish, 1 strain each of V. alginolyticus, V. vulnificus, and V. mimicus from diseased grouper (Epinephelus coioides), and V. alginolyticus from diseased seabass (Lates calcarifer). Bacterial susceptibility was expressed as minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The MIC and MBC values obtained for all V. harveyi isolates ranged from <0.3 to 1.25 µg/ml. For the non-luminous Vibrio species, MIC and MBC values ranged from <0.08 to 1.25 µg/ml. In vivo tolerance levels (24 h static bioassay) of larval and postlarval stages of P. monodon for Sarafin® were <10 µg/ml for nauplii, mysis, and postlarvae and ≤1 µg/ml for zoeae. Morphological deformities in the carapace, rostrum, and setae were noted among larvae exposed to >50 µg/ml Sarafin®. These results indicate that Sarafin® is a potential candidate as a chemotherapeutic agent against luminous vibriosis in P. monodon.
